Codeine induces increased resistance at the esophagogastric junction but has no effect on motility and bolus flow in the pharynx and upper esophageal sphincter in healthy volunteers: A randomized, double-blind, placebo-controlled, cross-over trial.
Adult
Analgesics, Opioid
/ pharmacology
Codeine
/ pharmacology
Cross-Over Studies
Double-Blind Method
Electric Impedance
Esophageal Sphincter, Upper
/ drug effects
Esophagogastric Junction
/ drug effects
Female
Gastrointestinal Motility
/ drug effects
Healthy Volunteers
Humans
Male
Manometry
Pharynx
/ drug effects
Codeine
acute setting
contractile activity and pressure flow parameters
esophageal body
pharynx
Journal
Neurogastroenterology and motility
ISSN: 1365-2982
Titre abrégé: Neurogastroenterol Motil
Pays: England
ID NLM: 9432572
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
revised:
11
10
2020
received:
18
07
2020
accepted:
02
11
2020
pubmed:
25
11
2020
medline:
1
1
2022
entrez:
24
11
2020
Statut:
ppublish
Résumé
Chronic opioid use can induce esophageal dysfunction with symptoms resembling achalasia and a manometric pattern of esophagogastric junction-outflow obstruction (EGJ-OO). However, the effect of opioids in acute setting on pharyngeal function and esophageal body contractility has not been investigated. After positioning the high-resolution impedance manometry (HRiM) catheter, codeine (60 mg) or placebo (glucose syrup) was infused intragastrically. Forty-five minutes post-infusion, participants received liquid, semi-solid, and solid boluses to assess esophageal and pharyngeal function. HRiM analysis was performed adhering to the Chicago classification v3.0. (CC v3.0). Pressure flow analysis (PFA) for the esophageal body and the pharynx was performed using the SwallowGateway™ online platform. Nineteen healthy volunteers (HV) [5 male; age 38.3] were included. After codeine administration, higher integrated relaxation pressure 4 s values resulted in significantly reduced deglutitive EGJ relaxation and distal latency was significantly shorter. Distal contractility was similar in both conditions. Bolus flow resistance at the EGJ and distention pressures increased significantly after codeine infusion. Based on CC v3.0, acute infusion of codeine induced EGJ-OO in six HV (p = 0.0003 vs. placebo). Codeine administration induced no significant alterations in any of the pharyngeal PFA metrics. In HV, acute administration of codeine increased bolus resistance at the EGJ secondary to induced incomplete EGJ relaxation leading to major motility disorders in a subset of subjects including EGJ-OO. However, an acute single dose of codeine did not affect motility or bolus flow in pharynx and UES. ClinicalTrials.gov number, NCT03784105.
Sections du résumé
BACKGROUND
Chronic opioid use can induce esophageal dysfunction with symptoms resembling achalasia and a manometric pattern of esophagogastric junction-outflow obstruction (EGJ-OO). However, the effect of opioids in acute setting on pharyngeal function and esophageal body contractility has not been investigated.
METHODS
After positioning the high-resolution impedance manometry (HRiM) catheter, codeine (60 mg) or placebo (glucose syrup) was infused intragastrically. Forty-five minutes post-infusion, participants received liquid, semi-solid, and solid boluses to assess esophageal and pharyngeal function. HRiM analysis was performed adhering to the Chicago classification v3.0. (CC v3.0). Pressure flow analysis (PFA) for the esophageal body and the pharynx was performed using the SwallowGateway™ online platform.
KEY RESULTS
Nineteen healthy volunteers (HV) [5 male; age 38.3] were included. After codeine administration, higher integrated relaxation pressure 4 s values resulted in significantly reduced deglutitive EGJ relaxation and distal latency was significantly shorter. Distal contractility was similar in both conditions. Bolus flow resistance at the EGJ and distention pressures increased significantly after codeine infusion. Based on CC v3.0, acute infusion of codeine induced EGJ-OO in six HV (p = 0.0003 vs. placebo). Codeine administration induced no significant alterations in any of the pharyngeal PFA metrics.
CONCLUSIONS & INFERENCES
In HV, acute administration of codeine increased bolus resistance at the EGJ secondary to induced incomplete EGJ relaxation leading to major motility disorders in a subset of subjects including EGJ-OO. However, an acute single dose of codeine did not affect motility or bolus flow in pharynx and UES. ClinicalTrials.gov number, NCT03784105.
Substances chimiques
Analgesics, Opioid
0
Codeine
UX6OWY2V7J
Banques de données
ClinicalTrials.gov
['NCT03784105']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14041Informations de copyright
© 2020 John Wiley & Sons Ltd.
Références
Serpell M. Handbook of Pain Management. London: Current Medicine Group; 2008.
Lacy BE. Effects of opioids on esophageal dysfunction. Gastroenterology & hepatology. 2016;12:323-325.
Porteous T, Bond C, Hannaford P, et al. How and why are non-prescription analgesics used in Scotland? Fam Pract. 2005;22:78-85.
Wood JD, Galligan JJ. Function of opioids in the enteric nervous system. Neurogastroenterol Motil. 2004;16(Suppl 2):17-28.
Brock C, Olesen SS, Olesen AE, et al. Opioid-induced bowel dysfunction: pathophysiology and management. Drugs. 2012;72:1847-1865.
Gonzalez ES, Bellver VO, Jaime FC, et al. Opioid-induced lower esophageal sphincter dysfunction. J Neurogastroenterol Motil. 2015;21:618-620.
Ratuapli SK, Crowell MD, DiBaise JK, et al. Opioid-induced esophageal dysfunction (OIED) in patients on chronic opioids. Am J Gastroenterol. 2015;110:979-984.
Cock C, Doeltgen SH, Omari T, et al. Effects of remifentanil on esophageal and esophagogastric junction (EGJ) bolus transit in healthy volunteers using novel pressure-flow analysis. Neurogastroenterol Motil. 2018;30(2):e13191. https://doi.org/10.1111/nmo.13191
Ortiz V, Garcia-Campos M, Saez-Gonzalez E, et al. A concise review of opioid-induced esophageal dysfunction: is this a new clinical entity? Dis Esophagus. 2018;31:1-6.
Snyder DL, Crowell MD, Horsley-Silva J, et al. Opioid-induced esophageal dysfunction: differential effects of type and dose. Am J Gastroenterol. 2019;114:1464-1469.
Snyder DL, Valdovinos LR, Horsley-Silva J, et al. Opioids interfere with deglutitive inhibition assessed by response to multiple rapid swallows during high-resolution esophageal manometry. Am J Gastroenterol. 2020;115:1125-1128.
Smiley RM, Moore RP. Loss of gag reflex and swallowing ability after administration of intrathecal fentanyl. Anesthesiology. 2007;106:1253.
Hardemark Cedborg AI, Sundman E, Boden K, et al. Effects of morphine and midazolam on pharyngeal function, airway protection, and coordination of breathing and swallowing in healthy adults. Anesthesiology. 2015;122:1253-1267.
Savilampi J, Magnuson A, Ahlstrand R. Effects of remifentanil on esophageal motility: a double-blind, randomized, cross-over study in healthy volunteers. Acta Anaesthesiol Scand. 2015;59:1126-1136.
Savilampi J, Ahlstrand R, Magnuson A, et al. Aspiration induced by remifentanil: a double-blind, randomized, crossover study in healthy volunteers. Anesthesiology. 2014;121:52-58.
Doeltgen SH, Omari TI, Savilampi J. Remifentanil alters sensory neuromodulation of swallowing in healthy volunteers: quantification by a novel pressure-impedance analysis. Am J Physiol Gastrointest Liver Physiol. 2016;310:G1176-G1182.
Patel DAK, Robert T, Vaezi MF. Evaluation and Management of Dysphagia. Berlin, Germany: Springer.
Ferris L, Omari T, Selleslagh M, et al. Pressure flow analysis in the assessment of preswallow pharyngeal bolus presence in Dysphagia. Int J Otolaryngol. 2015;2015:764709.
Penagini BB, Negri G, et al. Effect of loperamide on lower oesophageal sphincter pressure in idiopathic achalasia. Scand J Gastroenterol. 1994;29:1057-1060.
Penagini R, Picone A, Bianchi PA. Effect of morphine and naloxone on motor response of the human esophagus to swallowing and distension. Am J Physiol. 1996;271:G675-G680.
Scarpellini E, Pauwels A, Vos R, et al. Effect of methylnaltrexone and naloxone on esophageal motor function in man. Neurogastroenterol Motil. 2017;29:1-7.
Goelen N, de Hoon J, Morales JF, et al. Codeine delays gastric emptying through inhibition of gastric motility as assessed with a novel diagnostic intragastric balloon catheter. Neurogastroenterol Motil. 2020;32:e13733.
Smith HS. Opioid metabolism. Mayo Clin Proc. 2009;84:613-624.
Kirchheiner J, Schmidt H, Tzvetkov M, et al. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication. Pharmacogenomics J. 2007;7:257-265.
Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27:160-174.
Rattan S, Goyal RK. Identification and localization of opioid receptors in the opossum lower esophageal sphincter. J Pharmacol Exp Ther. 1983;224:391-397.
Barnette MS, Grous M, Manning CD, et al. Inhibition of neuronally induced relaxation of canine lower esophageal sphincter by opioid peptides. Eur J Pharmacol. 1990;182:363-368.
Savilampi J, Omari T, Magnuson A, et al. Effects of remifentanil on pharyngeal swallowing: a double blind randomised cross-over study in healthy volunteers. Eur J Anaesthesiol. 2016;33:622-630.
Storr M, Geisler F, Neuhuber WL, et al. Endomorphin-1 and -2, endogenous ligands for the mu-opioid receptor, inhibit striated and smooth muscle contraction in the rat oesophagus. Neurogastroenterol Motil. 2000;12:441-448.
Sawynok J, Pinsky C, LaBella FS. On the specificity of naloxone as an opiate antagonist. Life Sci. 1979;25:1621-1632.
Paterson SJ, Robson LE, Kosterlitz HW. Classification of opioid receptors. Br Med Bull. 1983;39:31-36.
Bradley CM, Nicholson AN. Effects of a mu-opioid receptor agonist (codeine phosphate) on visuo-motor coordination and dynamic visual acuity in man. Br J Clin Pharmacol. 1986;22:507-512.
Vieira CMP, Fragoso RM, Pereira D, et al. Pain polymorphisms and opioids: an evidence based review. Mol Med Rep. 2019;19:1423-1434.